Sort
39,280 grants matching “leukemia”
Immune Modulation After Allogeneic HCT
$2,740,234Robert Jon Soiffer · Dana-Farber Cancer Inst · P01 · FY2020 · CA
Immune Modulation After Allogeneic HCT
$2,739,426Robert Jon Soiffer · Dana-Farber Cancer Inst · P01 · FY2021 · CA
Bone Marrow Grafting and Cellular Therapy for Leukemia and Lymphoma
$2,739,423Robert S Negrin · Stanford University · P01 · FY2020 · CA
Pharmacogenetics of Anticancer Agents Research Group
$2,736,772Mark J Ratain · University Of Chicago · U01 · FY2009 · GM
Bone Marrow Grafting and Cellular Therapy for Leukemia and Lymphoma
$2,735,488Robert S Negrin · Stanford University · P01 · FY2021 · CA
Bone Marrow Grafting and Cellular Therapy for Leukemia and Lymphoma
$2,735,488Robert S Negrin · Stanford University · P01 · FY2023 · CA
Repository Services for epidemiology studies
$2,735,000David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2018 · CA
Genomics of Acute Myelogenous Leukemia
$2,733,974Timothy J Ley · Washington University · P01 · FY2011 · CA
PLCO Trial Etiologic and Early Marker Study
$2,731,838Ann Hsing · Division Of Cancer Epidemiology And Genetics · ZIA · FY2009 · CA
Center for the Spatiotemporal Modeling of Cell Signaling (STMC)
$2,730,711Bridget S Wilson · University Of New Mexico · P50 · FY2012 · GM
Systems Biology of Diversity in Cancer
$2,729,985Chris Sander · Sloan-Kettering Inst Can Research · U54 · FY2012 · CA
Genes and signals controlling mammalian hematopoiesis.
$2,727,753Paul E Love · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2025 · HD
SWOG Biospecimen Bank
$2,727,061Nilsa Del Carmen Ramirez · Research Inst Nationwide Children'S Hosp · U24 · FY2018 · CA
SWOG Biospecimen Bank to Support NCI NCTN
$2,724,055Nilsa Del Carmen Ramirez · Research Inst Nationwide Children'S Hosp · U24 · FY2024 · CA
Allogeneic and Autologous Immunotherapy for cancer and nonmalignant hematological disorders
$2,719,866Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2016 · HL
Systems Biology of Diversity in Cancer
$2,716,373Chris Sander · Sloan-Kettering Inst Can Research · U54 · FY2011 · CA
THERAPY OF CML
$2,715,148University Of Texas Md Anderson Can Ctr · P01 · FY2001 · CA
Mammalian Development and Evolution
$2,713,677Todd Scott Macfarlan · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2025 · HD
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
$2,710,901Thomas Waldmann · Division Of Basic Sciences - Nci · ZIB · FY2017 · CA
THE ALLIANCE NCTN BIOREPOSITORY AND BIOSPECIMEN RESOURCE
$2,706,967Mark A Watson · Washington University · U24 · FY2019 · CA
Systems Biology of Diversity in Cancer
$2,702,738Chris Sander · Sloan-Kettering Inst Can Research · U54 · FY2013 · CA
COG NCTN Network Group Operations Center
$2,702,029Richard Aplenc · Children'S Hosp Of Philadelphia · U10 · FY2020 · CA
Bone Marrow Grafting for Leukemia and Lymphoma
$2,700,000Robert S Negrin · Stanford University · P01 · FY2013 · CA
Bone Marrow Grafting for Leukemia and Lymphoma
$2,700,000Robert S Negrin · Stanford University · P01 · FY2017 · CA
Bone Marrow Grafting for Leukemia and Lymphoma
$2,700,000Robert S Negrin · Stanford University · P01 · FY2015 · CA